Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sevuparin
Therapeutic Area : Nephrology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Modus Gets Phase IIa Trial Approval for CKD Therapy in Clinical Advancements
Details : Modus is set to advance the clinical development of its lead product, Sevuparin, for the treatment of chronic kidney disease.
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
November 19, 2024
Lead Product(s) : Sevuparin
Therapeutic Area : Nephrology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
